This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

High Growth Stock Picks For Good Times And Bad

In Healthcare: In this sector the fund is taking some money off the table “We sold off C.R. Bard (BCR),” explains McIver. “It is a low cost provider but we had concerns about their execution as a business. We saw better growth opportunities elsewhere.” One top holding is Varian Medical Systems (VAR), a leading designer of radiation therapy services and equipment. Given the unfortunate rise of cancer, the firm has a real sweet spot as the market provider. Their business model also bodes well for its continued success:  When a customer (hospital) buys a product they also purchase upkeep and training for its staff, providing annuity down the road.

Consumer Staples: There’s more opportunity here with brands and franchises, many of which are not new to the oversea markets. The Coca-Cola Company (KO), remains a favorite in that sense. According to McIver “North Korea and Cuba are the only two countries in the world where you can’t buy a coke. The strength of the brand and franchise is strong. The stock has high return on equity, rewards shareholders, grows their dividend, and has strong cash flow. As an investor, would you buy a 10-year U.S bond, which yields 1.65%, or Coke, with a dividend of 2.69%? Coke is clearly more attractive.”   

Technology: Amphenol Corp (APH) is a leading designer and manufacturer of electric connectors. It’s a commodity-like business but they have positioned themselves to work with customers like Apple (AAPL), as well as bigger aerospace industries where they design connectors to improve efficiency. “We think it’s fairly priced to buy today. It tends to be more volatile because the market treats it so, but it has a lot of value and more growth to price in.”

Another technology stock in the fund is Waters Corporation (WAT), the leader in mass spectrometry. This is a process that measures and breaks down a substance’s compounds to identify and calculate all of its components. Healthcare companies have a great need for this technology, as do oil and gas companies which require this analysis for research.

Lastly, Praxair (PX), a leading industrial atmospheric gasses company. “This is a real interesting play,” says McIver. “The firm builds and operates plants near customers that requires their gas. The business model is typically long-term  contracts (3-20 years) with customers, which gives them a lot of security, so even if the customers don’t take the product they still have to pay, otherwise it would be too risky for Praxair to engage. Furthermore, the primary cost of its goods (air) is free.  The by-products are other gasses that Praxair will bottle up and sell to another customer, while the first customer has essentially paid the industrial cost. Praxair plays on energy and the growing strength of the emerging markets, especially in Latin America where has seen a lot of success.”

Advice for New Investors

“Moving from one shiny thing to the next tends to be harmful to your financial health,” cautions McIver. “Risk is very much a word investors are concerned about. To us, risk is the permanent loss of capital. Our strategy is proven over time, with lower volatility and superior returns, but it takes patience. An investor must understand the strategy and stick with it because in the long term, it tends to be successful.”

2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,776.43 +304.06 1.85%
S&P 500 1,987.05 +35.69 1.83%
NASDAQ 4,781.2640 +73.4890 1.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs